% (n/N) | Total | Responders (both baseline and 12 months) | Non-responders (baseline but not 12 months) | p-value* |
---|---|---|---|---|
Point prevalence | 45 (50/111) | 54 (36/67) | 32 (14/44) | .023 |
- in proactive service | 41 (23/56) | 50 (17/34) | 27 (6/22) | .091 |
- in reactive service | 49 (27/55) | 58 (19/33) | 36 (8/22) | .123 |
6-month continuous abstinence | 38 (42/110) | 49 (33/67) | 21 (9/43) | .003 |
- in proactive service | 34 (19/56) | 44 (15/34) | 18 (4/22) | .045 |
- in reactive service | 43 (23/54) | 55 (18/33) | 24 (5/21) | .026 |
Women | 75 (83/111) | 72 (48/67) | 79 (35/44) | .348 |
Age (median; q1-q3) | 50; 38–58 | 51; 41–59 | 45; 34–55 | .044 |
Pharmaceuticala use in the past 7 days | 20 (22/110) | 21 (14/67) | 19 (8/43) | .769 |
Pharmaceuticala use since first call to SNTQ: | ||||
- no | 41 (45/109) | 42 (28/66) | 39 (17/43) | .925 |
- yes, < 5 weeks | 19 (21/109) | 18 (12/66) | 21 (9/43) | |
- yes, ≥ 5 weeks | 39 (43/109) | 39 (26/66) | 39 (17/43) | |
Snus use in the past 7 days | 11 (12/109) | 12 (8/66) | 9 (4/43) | .761 |
Intention to quit (among still smokers): | ||||
- action + preparation | 49 (30/61) | 53 (17/32) | 45 (13/29) | .517 |
- contempl. + precont b | 51 (31/61) | 47 (15/32) | 55 (16/29) |